Cellectis (NASDAQ: CLLS) reported Q3 EPS of ($0.23), $0.03 worse than the analyst estimate of ($0.20). Revenue for the quarter came in at $18.05 million versus the consensus estimate of $9.77 million.

For earnings history and earnings-related data on Cellectis (CLLS) click here.